Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.51% | 13.80% | -22.86% | 17.20% | 23.98% |
| Total Depreciation and Amortization | -3.03% | 3.13% | 0.00% | -61.90% | -27.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.45% | 35.24% | 236.75% | -116.13% | -37.18% |
| Change in Net Operating Assets | 257.18% | 3.83% | 32.16% | -110.96% | 7,163.96% |
| Cash from Operations | 97.33% | 10.86% | 6.87% | -124.94% | 631.82% |
| Capital Expenditure | -- | 100.00% | 0.00% | 80.28% | 47.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -127.34% | 378.19% | -70.37% | 119.29% | -571.19% |
| Cash from Investing | -127.34% | 379.50% | -70.43% | 119.27% | -574.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.01% | 1,913.94% | 142.03% | 83.98% | -235.41% |